HSCS HeartSciences Inc.

Nasdaq heartsciences.com


$ 3.36 $ 0.00 (0 %)    

Monday, 20-Oct-2025 10:29:32 EDT
QQQ $ 611.95 $ 4.85 (0.8 %)
DIA $ 465.60 $ 2.17 (0.47 %)
SPY $ 670.87 $ 3.53 (0.53 %)
TLT $ 91.40 $ -0.05 (-0.05 %)
GLD $ 400.08 $ 2.69 (0.68 %)
$ 3.33
$ 3.41
$ 3.35 x 2
$ 3.43 x 25
-- - --
$ 2.52 - $ 6.47
24,059
na
8.82M
$ 2.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-11-2025 07-31-2025 10-Q
2 07-24-2025 04-30-2025 10-K
3 03-13-2025 01-31-2025 10-Q
4 12-16-2024 10-31-2024 10-Q
5 09-12-2024 07-31-2024 10-Q
6 07-29-2024 04-30-2024 10-K
7 03-14-2024 01-31-2024 10-Q
8 12-14-2023 10-31-2023 10-Q
9 09-14-2023 07-31-2023 10-Q
10 07-18-2023 04-30-2023 10-K
11 03-16-2023 01-31-2023 10-Q
12 12-15-2022 10-31-2022 10-Q
13 09-12-2022 07-31-2022 10-Q
14 07-29-2022 04-30-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ascendiant-capital-maintains-buy-on-heartsciences-lowers-price-target-to-9

Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $15 ...

 heartsciences-q1-eps-158-beats-209-estimate-sales-1900m

HeartSciences Inc. (NASDAQ:HSCS) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(...

 heartsciences-announces-25m-offering

-SEC Filing

 heart-test-laboratories-q4-eps-186-beats-225-estimate-sales-4350m

Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(1.86) per share which beat the analyst consensus estimate ...

 heartsciences-signs-first-commercial-customer-westcliffe-health-innovations-uk-for-its-ai-powered-myovista-insights-platform

HeartSciences Inc. (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), an artificial intelligence ("...

 ascendiant-capital-maintains-buy-on-heartsciences-lowers-price-target-to-14

Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $15 ...

 maxim-group-reiterates-buy-on-heartsciences-maintains-12-price-target

Maxim Group analyst Allen Klee reiterates HeartSciences (NASDAQ:HSCS) with a Buy and maintains $12 price target.

 heart-test-laboratories-q2-eps-227-beats-243-estimate

Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(2.27) per share which beat the analyst consensus estimate ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION